ID
18482
Description
Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure; ODM derived from: https://clinicaltrials.gov/show/NCT00109655
Link
https://clinicaltrials.gov/show/NCT00109655
Keywords
Versions (1)
- 11/7/16 11/7/16 -
Uploaded on
November 7, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Carcinoma, Transitional Cell NCT00109655
Eligibility Carcinoma, Transitional Cell NCT00109655
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Pregnancy | Breast Feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
HIV Seropositivity
Data type
boolean
Alias
- UMLS CUI [1]
- C0019699
Description
Anticoagulants
Data type
boolean
Alias
- UMLS CUI [1]
- C0003280
Description
Bleeding Risk
Data type
boolean
Alias
- UMLS CUI [1]
- C3251812
Description
Autoimmune Diseases | Immunologic Deficiency Syndromes
Data type
boolean
Alias
- UMLS CUI [1]
- C0004364
- UMLS CUI [2]
- C0021051
Description
gene therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0017296
Description
Cystitis | Bladder pain | Bladder spasm | Urinary Incontinence | Reduced bladder capacity
Data type
boolean
Alias
- UMLS CUI [1]
- C0010692
- UMLS CUI [2]
- C0232849
- UMLS CUI [3]
- C0426390
- UMLS CUI [4]
- C0042024
- UMLS CUI [5]
- C2721720
Similar models
Eligibility Carcinoma, Transitional Cell NCT00109655
- StudyEvent: Eligibility
C3179006 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0005778 (UMLS CUI [4])
C0006147 (UMLS CUI [2])
C0021051 (UMLS CUI [2])
C0232849 (UMLS CUI [2])
C0426390 (UMLS CUI [3])
C0042024 (UMLS CUI [4])
C2721720 (UMLS CUI [5])